← Back to Clinical Trials
Recruiting NCT02877706

NCT02877706 French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02877706
Status Recruiting
Phase —
Sponsor University Hospital, Toulouse
Condition Immune Thrombocytopenia
Study Type OBSERVATIONAL
Enrollment 1,500 participants
Start Date 2013-06
Primary Completion 2026-12

Trial Parameters

Condition Immune Thrombocytopenia
Sponsor University Hospital, Toulouse
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2013-06
Completion 2026-12
Interventions
no specific intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

CARMEN is a national, real-world clinical registry of all adult patients with incident diagnosis of Immune thrombocytopenia (ITP) or Autoimmune Hemolytic anemia (AIHA) patients in France. It is aimed at describing ITP and AIHA clinical features, assessing the real-world risk-benefit ratio of treatments and adherence to guidelines for ITP and AIHA management.

Eligibility Criteria

Inclusion Criteria: * adult patients (18+ year-old) * newly diagnosed for ITP/AIHA or initiation of FOSFAMATINIB Exclusion criteria: \- opposition to data collection

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE IMMUNE THROMBOCYTOPENIA TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology